397 related articles for article (PubMed ID: 6744543)
21. Atypical patterns of retrograde conduction over accessory atrioventricular pathways in the Wolff-Parkinson-White syndrome.
Klein GJ; Prystowsky EN; Pritchett EL; Davis D; Gallagher JJ
Circulation; 1979 Dec; 60(7):1477-86. PubMed ID: 498475
[TBL] [Abstract][Full Text] [Related]
22. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
23. Intracardiac electrode catheter recordings of atrioventricular bypass tracts in Wolff-Parkinson-White syndrome: techniques, electrophysiologic characteristics and demonstration of concealed and decremental propagation.
Winters SL; Gomes JA
J Am Coll Cardiol; 1986 Jun; 7(6):1392-403. PubMed ID: 3711497
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
25. 'Dual atrioventricular nodal pathways" in patients with Wolff-Parkinson-White syndrome.
Pritchett EL; Prystowsky EN; Benditt DG; Gallagher JJ
Br Heart J; 1980 Jan; 43(1):7-13. PubMed ID: 7356864
[TBL] [Abstract][Full Text] [Related]
26. Retrograde supernormal conduction, gap phenomenon in concealed accessory atrioventricular pathways.
Suzuki F; Harada TO; Nawata H; Ohtomo K; Satoh T; Hirao K; Hiejima K
Pacing Clin Electrophysiol; 1992 Jul; 15(7):1065-79. PubMed ID: 1378598
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiologic characteristics, electropharmacologic responses and radiofrequency ablation in patients with decremental accessory pathway.
Chen SA; Tai CT; Chiang CE; Lee SH; Wen ZC; Chiou CW; Ueng KC; Chen YJ; Yu WC; Huang JL; Chang MS
J Am Coll Cardiol; 1996 Sep; 28(3):732-7. PubMed ID: 8772764
[TBL] [Abstract][Full Text] [Related]
28. Role of atrial fibrillation and atrioventricular conduction (including Wolff-Parkinson-White syndrome) in sudden death.
Meijler FL; van der Tweel I; Herbschleb JN; Hauer RN; Robles de Medina EO
J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):17B-22B. PubMed ID: 3998333
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Ludmer PL; McGowan NE; Antman EM; Friedman PL
J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
[TBL] [Abstract][Full Text] [Related]
30. Functional properties of accessory atrioventricular pathways in Wolff-Parkinson-White syndrome. Clinical implications.
German LD; Gallagher JJ
Am J Med; 1984 Jun; 76(6):1079-86. PubMed ID: 6731464
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological determinants of antidromic reentry induced during atrial extrastimulation. Insights from a pacing model of Wolff-Parkinson-White syndrome.
Lehmann MH; Tchou P; Mahmud R; Denker ST; Akhtar M
Circ Res; 1989 Aug; 65(2):295-306. PubMed ID: 2752541
[TBL] [Abstract][Full Text] [Related]
32. Patterns of atrial activation during right ventricular pacing in patients with concealed left-sided Kent pathways.
Ward DE; Camm AJ; Spurrell RA
Br Heart J; 1979 Aug; 42(2):192-200. PubMed ID: 486281
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
34. Characterization of retrograde conduction by direct endocardial recording from an accessory atrioventricular pathway.
O'Callaghan WG; Colavita PG; Kay GN; Ellenbogen KA; Gilbert MR; German LD
J Am Coll Cardiol; 1986 Jan; 7(1):167-71. PubMed ID: 3941206
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of spontaneous tachycardia termination in a patient with the Wolff-Parkinson-White syndrome and dual atrioventricular nodal pathways.
Adams JR; Hess D; Scheinman MM
Pacing Clin Electrophysiol; 1981 Jul; 4(4):367-75. PubMed ID: 6167953
[TBL] [Abstract][Full Text] [Related]
36. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
37. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.
Sharma AD; Klein GJ; Guiraudon GM; Milstein S
Circulation; 1985 Jul; 72(1):161-9. PubMed ID: 4006127
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of clinical and electrophysiologic characteristics of patients with occult and manifest atrioventricular accessory pathway].
Bottoni N; Donateo P; Tomasi C; Lolli G; Oddone D; Croci F; Menozzi C; Brignole M
Ital Heart J Suppl; 2001 Aug; 2(8):888-93. PubMed ID: 11582721
[TBL] [Abstract][Full Text] [Related]
39. Effects of isoproterenol on accessory pathway conduction in intermittent or concealed Wolff-Parkinson-White syndrome.
Yamamoto T; Yeh SJ; Lin FC; Wu DL
Am J Cardiol; 1990 Jun; 65(22):1438-42. PubMed ID: 2353648
[TBL] [Abstract][Full Text] [Related]
40. [Electrophysiologic effects of isoproterenol in children with Wolff-Parkinson-White syndrome].
Fujiseki Y; Fujino H; Hattori M; Kamiya Y; Nishijima S; Umemura N; Shimada M; Sugiyama T; Matsukawa S; Nishikawa R
Kokyu To Junkan; 1989 Feb; 37(2):189-94. PubMed ID: 2727406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
